Cyndeo Wealth Partners LLC Has $14.31 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Cyndeo Wealth Partners LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 27,327 shares of the healthcare conglomerate's stock after selling 2,788 shares during the quarter. UnitedHealth Group accounts for approximately 0.9% of Cyndeo Wealth Partners LLC's investment portfolio, making the stock its 26th largest position. Cyndeo Wealth Partners LLC's holdings in UnitedHealth Group were worth $14,312,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Financial Management Professionals Inc. increased its position in UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after purchasing an additional 17 shares during the period. Richwood Investment Advisors LLC increased its position in UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after purchasing an additional 20 shares during the period. Global Wealth Strategies & Associates increased its position in UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after purchasing an additional 20 shares during the period. 44 Wealth Management LLC increased its position in UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock valued at $662,000 after purchasing an additional 21 shares during the period. Finally, Prentice Wealth Management LLC increased its position in UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock valued at $1,278,000 after purchasing an additional 21 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Activity at UnitedHealth Group

In related news, Director John H. Noseworthy bought 300 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the acquisition, the director now directly owns 6,063 shares of the company's stock, valued at $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer now directly owns 10,398 shares of the company's stock, valued at $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have bought 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Down 1.6%

NYSE UNH opened at $313.39 on Monday. The stock has a market capitalization of $284.28 billion, a price-to-earnings ratio of 20.22, a PEG ratio of 1.37 and a beta of 0.44. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business's fifty day moving average is $386.66 and its 200-day moving average is $472.32.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the firm earned $6.91 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a $2.21 dividend. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.82%. The ex-dividend date is Monday, June 16th. UnitedHealth Group's payout ratio is currently 37.02%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. KeyCorp reduced their price objective on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a research report on Monday, June 2nd. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Oppenheimer reduced their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday, May 14th. Mizuho reduced their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Finally, Bank of America cut UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their target price for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $426.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.